Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Merk

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Journal of the American Chemical Society|February 25, 2026
Hydrophobic Refinement of Polarity-Switchable Lipo-Xenopeptides Modulates Endosomal Escape and Enhances mRNA Delivery In Vitro and In VivoTobias Burghardt, Sophie Thalmayr, Lennart Obeser, et al.
Journal of Medicinal Chemistry|December 8, 2023
Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist PotencyGustave Adouvi, Felix Nawa, Marco Ballarotto, et al.
Journal of the American Chemical Society|June 29, 2023
Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ ModulationSilvia Arifi, Julian A Marschner, Julius Pollinger, et al.
Nature Communications|September 11, 2024
Automated design of multi-target ligands by generative deep learningLaura Isigkeit, Tim Hörmann, Espen Schallmayer, et al.
Antiviral Research|June 16, 2025
RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP traffickingSameh A Gad, Doaa A Abo Elwafa, Saied A Hussein, et al.
ACS Chemical Biology|November 1, 2022
Mechanistic Impact of Different Ligand Scaffolds on FXR Modulation Suggests Avenues to Selective ModulatorsJan Heering, Nathalie Jores, Whitney Kilu, et al.
Journal of the American Chemical Society|August 4, 2025
Targeting the SARS-CoV-2 RNA Translation Initiation Element SL1 by Molecules of Low Molecular WeightSabrina Toews, Francesca Donà, Marco Keller, et al.
Bioorganic & Medicinal Chemistry|September 25, 2019
Structure optimization of a new class of PPARγ antagonistsVictor Hernandez-Olmos, Tilo Knape, Jan Heering, et al.
Biochemical Pharmacology|July 30, 2022
Compilation and evaluation of a fatty acid mimetics screening libraryJohanna H M Ehrler, Steffen Brunst, Amelie Tjaden, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 27, 2021
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo DesignLukas Friedrich, Gino Cingolani, Ying-Hui Ko, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Journal of the American Chemical Society|February 25, 2026
Hydrophobic Refinement of Polarity-Switchable Lipo-Xenopeptides Modulates Endosomal Escape and Enhances mRNA Delivery In Vitro and In VivoTobias Burghardt, Sophie Thalmayr, Lennart Obeser, et al.
Journal of Medicinal Chemistry|December 8, 2023
Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist PotencyGustave Adouvi, Felix Nawa, Marco Ballarotto, et al.
Journal of the American Chemical Society|June 29, 2023
Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ ModulationSilvia Arifi, Julian A Marschner, Julius Pollinger, et al.
Nature Communications|September 11, 2024
Automated design of multi-target ligands by generative deep learningLaura Isigkeit, Tim Hörmann, Espen Schallmayer, et al.
Antiviral Research|June 16, 2025
RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP traffickingSameh A Gad, Doaa A Abo Elwafa, Saied A Hussein, et al.
ACS Chemical Biology|November 1, 2022
Mechanistic Impact of Different Ligand Scaffolds on FXR Modulation Suggests Avenues to Selective ModulatorsJan Heering, Nathalie Jores, Whitney Kilu, et al.
Journal of the American Chemical Society|August 4, 2025
Targeting the SARS-CoV-2 RNA Translation Initiation Element SL1 by Molecules of Low Molecular WeightSabrina Toews, Francesca Donà, Marco Keller, et al.
Bioorganic & Medicinal Chemistry|September 25, 2019
Structure optimization of a new class of PPARγ antagonistsVictor Hernandez-Olmos, Tilo Knape, Jan Heering, et al.
Biochemical Pharmacology|July 30, 2022
Compilation and evaluation of a fatty acid mimetics screening libraryJohanna H M Ehrler, Steffen Brunst, Amelie Tjaden, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 27, 2021
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo DesignLukas Friedrich, Gino Cingolani, Ying-Hui Ko, et al.
Pageof 17